Loading…

High-throughput screening of cytochrome P450 (CYP) family of genes in primary and recurrent pterygium

Pterygium is a common degenerative disease characterized by fibrovascular outgrowth towards cornea. Around 200 million people have been reported to be affected by the pterygium in the world. Although the risk factors for pterygium are well documented, the molecular pathogenesis of pterygium seems to...

Full description

Saved in:
Bibliographic Details
Published in:Experimental eye research 2023-08, Vol.233, p.109522-109522, Article 109522
Main Authors: Okumus, Seydi, Ozcan, Eyup, Erbagci, Ibrahim
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c356t-3ca0bcadd48694bd3d4f44dad6655451b62ff93717187b2ceda55e60251ec1ca3
cites cdi_FETCH-LOGICAL-c356t-3ca0bcadd48694bd3d4f44dad6655451b62ff93717187b2ceda55e60251ec1ca3
container_end_page 109522
container_issue
container_start_page 109522
container_title Experimental eye research
container_volume 233
creator Okumus, Seydi
Ozcan, Eyup
Erbagci, Ibrahim
description Pterygium is a common degenerative disease characterized by fibrovascular outgrowth towards cornea. Around 200 million people have been reported to be affected by the pterygium in the world. Although the risk factors for pterygium are well documented, the molecular pathogenesis of pterygium seems to be very complex and remains highly elusive. However, the common sense for the development of pterygium appears to be deregulation of growth hemostasis due to aberrant apoptosis. In addition, pterygium shares many features with human cancers, including dysregulation of apoptosis, persistent proliferation, inflammation, invasion, and relapse following resection. Cytochrome P450 (CYP) monooxygenases are a superfamily of heme-containing enzymes with a wide range of structural and functional diversity. In the present study, we aimed to identify significant expression signatures of CYP gene in pterygium. For the study, a total number of 45 patients (30 primary and 15 recurrent pterygium) were included. For the high-throughput screening of CYP gene expression, Fluidigm 96.96 Dynamic Array Expression Chip was used and analyzed with BioMark™ HD System Real-Time PCR system. Remarkably, CYP genes were identified to be significantly overexpressed in both primary and recurrent pterygium samples. Most prominent overexpression was observed in CYP1A1, CYP11B2 and CYP4F2 in primary pterygium and CYP11A1 and CYP11B2 in recurrent pterygium. Consequently, present findings suggest the significant involvement of CYP genes in the development and progression of pterygium. •Human CYP genes are significantly overexpressed pterygium.•CYP1A1, CYP11B2 and CYP4F2 were upregulated in primary pterygium.•CYP11A1 and CYP11B2 were upregulated in recurrent pterygium.
doi_str_mv 10.1016/j.exer.2023.109522
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2822708407</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0014483523001434</els_id><sourcerecordid>2822708407</sourcerecordid><originalsourceid>FETCH-LOGICAL-c356t-3ca0bcadd48694bd3d4f44dad6655451b62ff93717187b2ceda55e60251ec1ca3</originalsourceid><addsrcrecordid>eNp9kMtOwzAQRS0EouXxAyyQl7BI8TNOJTao4iUh0QUsWFmOPUldNUmxE0T_HlctLFnNaObeq5mD0AUlE0pofrOcwDeECSOMp8FUMnaAxqnJM0KIOkRjQqjIRMHlCJ3EuExTLpQ4RiOumKKckjGCJ18vsn4RuqFerIceRxsAWt_WuKuw3fSdTbsG8FxIgq9mH_NrXJnGrzbbfQ0tROxbvA6-MWGDTetwADuEAG2P1z2ETe2H5gwdVWYV4XxfT9H7w_3b7Cl7eX18nt29ZJbLvM-4NaS0xjlR5FNROu5EJYQzLs-lFJKWOauqKVdU0UKVzIIzUkJOmKRgqTX8FF3tcteh-xwg9rrx0cJqZVrohqhZwZgihSAqSdlOakMXY4BK73_QlOgtXr3UW7x6i1fv8CbT5T5_KBtwf5ZfnklwuxNA-vLLJ3u0Htp0qU9Yeu06_1_-D7a6i9E</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2822708407</pqid></control><display><type>article</type><title>High-throughput screening of cytochrome P450 (CYP) family of genes in primary and recurrent pterygium</title><source>ScienceDirect Freedom Collection 2022-2024</source><creator>Okumus, Seydi ; Ozcan, Eyup ; Erbagci, Ibrahim</creator><creatorcontrib>Okumus, Seydi ; Ozcan, Eyup ; Erbagci, Ibrahim</creatorcontrib><description>Pterygium is a common degenerative disease characterized by fibrovascular outgrowth towards cornea. Around 200 million people have been reported to be affected by the pterygium in the world. Although the risk factors for pterygium are well documented, the molecular pathogenesis of pterygium seems to be very complex and remains highly elusive. However, the common sense for the development of pterygium appears to be deregulation of growth hemostasis due to aberrant apoptosis. In addition, pterygium shares many features with human cancers, including dysregulation of apoptosis, persistent proliferation, inflammation, invasion, and relapse following resection. Cytochrome P450 (CYP) monooxygenases are a superfamily of heme-containing enzymes with a wide range of structural and functional diversity. In the present study, we aimed to identify significant expression signatures of CYP gene in pterygium. For the study, a total number of 45 patients (30 primary and 15 recurrent pterygium) were included. For the high-throughput screening of CYP gene expression, Fluidigm 96.96 Dynamic Array Expression Chip was used and analyzed with BioMark™ HD System Real-Time PCR system. Remarkably, CYP genes were identified to be significantly overexpressed in both primary and recurrent pterygium samples. Most prominent overexpression was observed in CYP1A1, CYP11B2 and CYP4F2 in primary pterygium and CYP11A1 and CYP11B2 in recurrent pterygium. Consequently, present findings suggest the significant involvement of CYP genes in the development and progression of pterygium. •Human CYP genes are significantly overexpressed pterygium.•CYP1A1, CYP11B2 and CYP4F2 were upregulated in primary pterygium.•CYP11A1 and CYP11B2 were upregulated in recurrent pterygium.</description><identifier>ISSN: 0014-4835</identifier><identifier>EISSN: 1096-0007</identifier><identifier>DOI: 10.1016/j.exer.2023.109522</identifier><identifier>PMID: 37271310</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Apoptosis ; Cell proliferation ; CYP ; Cytochrome P-450 CYP11B2 ; Cytochrome P-450 Enzyme System - genetics ; Cytochrome P-450 Enzyme System - metabolism ; High-Throughput Screening Assays ; Humans ; P450 cytochrome ; Pterygium ; Pterygium - metabolism</subject><ispartof>Experimental eye research, 2023-08, Vol.233, p.109522-109522, Article 109522</ispartof><rights>2023 Elsevier Ltd</rights><rights>Copyright © 2023 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c356t-3ca0bcadd48694bd3d4f44dad6655451b62ff93717187b2ceda55e60251ec1ca3</citedby><cites>FETCH-LOGICAL-c356t-3ca0bcadd48694bd3d4f44dad6655451b62ff93717187b2ceda55e60251ec1ca3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37271310$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Okumus, Seydi</creatorcontrib><creatorcontrib>Ozcan, Eyup</creatorcontrib><creatorcontrib>Erbagci, Ibrahim</creatorcontrib><title>High-throughput screening of cytochrome P450 (CYP) family of genes in primary and recurrent pterygium</title><title>Experimental eye research</title><addtitle>Exp Eye Res</addtitle><description>Pterygium is a common degenerative disease characterized by fibrovascular outgrowth towards cornea. Around 200 million people have been reported to be affected by the pterygium in the world. Although the risk factors for pterygium are well documented, the molecular pathogenesis of pterygium seems to be very complex and remains highly elusive. However, the common sense for the development of pterygium appears to be deregulation of growth hemostasis due to aberrant apoptosis. In addition, pterygium shares many features with human cancers, including dysregulation of apoptosis, persistent proliferation, inflammation, invasion, and relapse following resection. Cytochrome P450 (CYP) monooxygenases are a superfamily of heme-containing enzymes with a wide range of structural and functional diversity. In the present study, we aimed to identify significant expression signatures of CYP gene in pterygium. For the study, a total number of 45 patients (30 primary and 15 recurrent pterygium) were included. For the high-throughput screening of CYP gene expression, Fluidigm 96.96 Dynamic Array Expression Chip was used and analyzed with BioMark™ HD System Real-Time PCR system. Remarkably, CYP genes were identified to be significantly overexpressed in both primary and recurrent pterygium samples. Most prominent overexpression was observed in CYP1A1, CYP11B2 and CYP4F2 in primary pterygium and CYP11A1 and CYP11B2 in recurrent pterygium. Consequently, present findings suggest the significant involvement of CYP genes in the development and progression of pterygium. •Human CYP genes are significantly overexpressed pterygium.•CYP1A1, CYP11B2 and CYP4F2 were upregulated in primary pterygium.•CYP11A1 and CYP11B2 were upregulated in recurrent pterygium.</description><subject>Apoptosis</subject><subject>Cell proliferation</subject><subject>CYP</subject><subject>Cytochrome P-450 CYP11B2</subject><subject>Cytochrome P-450 Enzyme System - genetics</subject><subject>Cytochrome P-450 Enzyme System - metabolism</subject><subject>High-Throughput Screening Assays</subject><subject>Humans</subject><subject>P450 cytochrome</subject><subject>Pterygium</subject><subject>Pterygium - metabolism</subject><issn>0014-4835</issn><issn>1096-0007</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNp9kMtOwzAQRS0EouXxAyyQl7BI8TNOJTao4iUh0QUsWFmOPUldNUmxE0T_HlctLFnNaObeq5mD0AUlE0pofrOcwDeECSOMp8FUMnaAxqnJM0KIOkRjQqjIRMHlCJ3EuExTLpQ4RiOumKKckjGCJ18vsn4RuqFerIceRxsAWt_WuKuw3fSdTbsG8FxIgq9mH_NrXJnGrzbbfQ0tROxbvA6-MWGDTetwADuEAG2P1z2ETe2H5gwdVWYV4XxfT9H7w_3b7Cl7eX18nt29ZJbLvM-4NaS0xjlR5FNROu5EJYQzLs-lFJKWOauqKVdU0UKVzIIzUkJOmKRgqTX8FF3tcteh-xwg9rrx0cJqZVrohqhZwZgihSAqSdlOakMXY4BK73_QlOgtXr3UW7x6i1fv8CbT5T5_KBtwf5ZfnklwuxNA-vLLJ3u0Htp0qU9Yeu06_1_-D7a6i9E</recordid><startdate>202308</startdate><enddate>202308</enddate><creator>Okumus, Seydi</creator><creator>Ozcan, Eyup</creator><creator>Erbagci, Ibrahim</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202308</creationdate><title>High-throughput screening of cytochrome P450 (CYP) family of genes in primary and recurrent pterygium</title><author>Okumus, Seydi ; Ozcan, Eyup ; Erbagci, Ibrahim</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c356t-3ca0bcadd48694bd3d4f44dad6655451b62ff93717187b2ceda55e60251ec1ca3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Apoptosis</topic><topic>Cell proliferation</topic><topic>CYP</topic><topic>Cytochrome P-450 CYP11B2</topic><topic>Cytochrome P-450 Enzyme System - genetics</topic><topic>Cytochrome P-450 Enzyme System - metabolism</topic><topic>High-Throughput Screening Assays</topic><topic>Humans</topic><topic>P450 cytochrome</topic><topic>Pterygium</topic><topic>Pterygium - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Okumus, Seydi</creatorcontrib><creatorcontrib>Ozcan, Eyup</creatorcontrib><creatorcontrib>Erbagci, Ibrahim</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Experimental eye research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Okumus, Seydi</au><au>Ozcan, Eyup</au><au>Erbagci, Ibrahim</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>High-throughput screening of cytochrome P450 (CYP) family of genes in primary and recurrent pterygium</atitle><jtitle>Experimental eye research</jtitle><addtitle>Exp Eye Res</addtitle><date>2023-08</date><risdate>2023</risdate><volume>233</volume><spage>109522</spage><epage>109522</epage><pages>109522-109522</pages><artnum>109522</artnum><issn>0014-4835</issn><eissn>1096-0007</eissn><abstract>Pterygium is a common degenerative disease characterized by fibrovascular outgrowth towards cornea. Around 200 million people have been reported to be affected by the pterygium in the world. Although the risk factors for pterygium are well documented, the molecular pathogenesis of pterygium seems to be very complex and remains highly elusive. However, the common sense for the development of pterygium appears to be deregulation of growth hemostasis due to aberrant apoptosis. In addition, pterygium shares many features with human cancers, including dysregulation of apoptosis, persistent proliferation, inflammation, invasion, and relapse following resection. Cytochrome P450 (CYP) monooxygenases are a superfamily of heme-containing enzymes with a wide range of structural and functional diversity. In the present study, we aimed to identify significant expression signatures of CYP gene in pterygium. For the study, a total number of 45 patients (30 primary and 15 recurrent pterygium) were included. For the high-throughput screening of CYP gene expression, Fluidigm 96.96 Dynamic Array Expression Chip was used and analyzed with BioMark™ HD System Real-Time PCR system. Remarkably, CYP genes were identified to be significantly overexpressed in both primary and recurrent pterygium samples. Most prominent overexpression was observed in CYP1A1, CYP11B2 and CYP4F2 in primary pterygium and CYP11A1 and CYP11B2 in recurrent pterygium. Consequently, present findings suggest the significant involvement of CYP genes in the development and progression of pterygium. •Human CYP genes are significantly overexpressed pterygium.•CYP1A1, CYP11B2 and CYP4F2 were upregulated in primary pterygium.•CYP11A1 and CYP11B2 were upregulated in recurrent pterygium.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>37271310</pmid><doi>10.1016/j.exer.2023.109522</doi><tpages>1</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0014-4835
ispartof Experimental eye research, 2023-08, Vol.233, p.109522-109522, Article 109522
issn 0014-4835
1096-0007
language eng
recordid cdi_proquest_miscellaneous_2822708407
source ScienceDirect Freedom Collection 2022-2024
subjects Apoptosis
Cell proliferation
CYP
Cytochrome P-450 CYP11B2
Cytochrome P-450 Enzyme System - genetics
Cytochrome P-450 Enzyme System - metabolism
High-Throughput Screening Assays
Humans
P450 cytochrome
Pterygium
Pterygium - metabolism
title High-throughput screening of cytochrome P450 (CYP) family of genes in primary and recurrent pterygium
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T11%3A20%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=High-throughput%20screening%20of%20cytochrome%20P450%20(CYP)%20family%20of%20genes%20in%20primary%20and%20recurrent%20pterygium&rft.jtitle=Experimental%20eye%20research&rft.au=Okumus,%20Seydi&rft.date=2023-08&rft.volume=233&rft.spage=109522&rft.epage=109522&rft.pages=109522-109522&rft.artnum=109522&rft.issn=0014-4835&rft.eissn=1096-0007&rft_id=info:doi/10.1016/j.exer.2023.109522&rft_dat=%3Cproquest_cross%3E2822708407%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c356t-3ca0bcadd48694bd3d4f44dad6655451b62ff93717187b2ceda55e60251ec1ca3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2822708407&rft_id=info:pmid/37271310&rfr_iscdi=true